Title |
Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus
|
---|---|
Published in |
Cochrane database of systematic reviews, December 2018
|
DOI | 10.1002/14651858.cd005061.pub3 |
Pubmed ID | |
Authors |
Suzanne VL Moelands, Peter LBJ Lucassen, Reinier P Akkermans, Wim JC De Grauw, Floris A Van de Laar |
X Demographics
The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 2 | 8% |
United Kingdom | 2 | 8% |
Spain | 2 | 8% |
El Salvador | 1 | 4% |
United States | 1 | 4% |
Mexico | 1 | 4% |
Finland | 1 | 4% |
France | 1 | 4% |
New Zealand | 1 | 4% |
Other | 1 | 4% |
Unknown | 11 | 46% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 19 | 79% |
Practitioners (doctors, other healthcare professionals) | 4 | 17% |
Scientists | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 661 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 661 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 96 | 15% |
Student > Bachelor | 95 | 14% |
Researcher | 52 | 8% |
Student > Ph. D. Student | 40 | 6% |
Student > Postgraduate | 31 | 5% |
Other | 93 | 14% |
Unknown | 254 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 174 | 26% |
Nursing and Health Professions | 78 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 19 | 3% |
Biochemistry, Genetics and Molecular Biology | 19 | 3% |
Sports and Recreations | 16 | 2% |
Other | 86 | 13% |
Unknown | 269 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2023.
All research outputs
#1,647,370
of 25,461,852 outputs
Outputs from Cochrane database of systematic reviews
#3,540
of 12,090 outputs
Outputs of similar age
#37,447
of 446,249 outputs
Outputs of similar age from Cochrane database of systematic reviews
#88
of 171 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,090 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.2. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,249 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 171 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.